Related Experiment Videos
Primary immunodeficiency diseases in Norway.
A Stray-Pedersen1, T G Abrahamsen, S S Frøland
1The Centre for Rare Disorders, Department of Medicine, Rikshospitalet, University of Oslo, Norway.
Journal of Clinical Immunology
|February 24, 2001
Summary
Norway
Area of Science:
- Immunology
- Epidemiology
Background:
- Primary immunodeficiency diseases (PIDs) are a heterogeneous group of disorders.
- Epidemiological data on PIDs are crucial for understanding disease burden and healthcare needs.
Purpose of the Study:
- To conduct the first national epidemiological survey of PIDs in Norway.
- To determine the prevalence and distribution of different PID types in Norway.
Main Methods:
- A nationwide survey using uniform questionnaires distributed to relevant hospital departments.
- Data collection from April 1998 to February 1999.
Main Results:
- A total of 372 patients with PIDs were registered in Norway (population 4.45 million).
- The overall prevalence of PIDs was 6.82 per 100,000 inhabitants.
- Distribution: antibody deficiencies (50.8%), combined deficiencies (12.4%), complement deficiencies (21.0%), phagocytic disorders (6.7%), and PIDs with other congenital diseases (9.1%).
- Norway shows a lower proportion of antibody deficiencies and a higher proportion of complement deficiencies compared to other European countries.
Conclusions:
- This study provides the first comprehensive epidemiological data on PIDs in Norway.
- The prevalence and specific distribution patterns of PIDs in Norway differ from other European nations, notably with a higher rate of complement deficiencies.
- Findings highlight the need for tailored public health strategies for PID management in Norway.